Loading…

Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells

Epstein‐Barr virus (EBV)‐encoded latent membrane protein 1 (LMP‐1) is essential for immortalization of B cells by EBV, protects the infected cells from apoptotic cell death and induces Bcl‐2 expression. Suppression of LMP‐1 expression by antisense oligodeoxynucleotides (AS‐oligo) to LMP‐1 inhibits p...

Full description

Saved in:
Bibliographic Details
Published in:British journal of haematology 2001-07, Vol.114 (1), p.84-92
Main Authors: Noguchi, Toshio, Ikeda, Kazuma, Yamamoto, Kazuhiko, Yoshida, Isao, Ashiba, Atsuko, Tsuchiyama, Junjiro, Shinagawa, Katsuji, Yoshino, Tadashi, Takata, Minoru, Harada, Mine
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3
cites cdi_FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3
container_end_page 92
container_issue 1
container_start_page 84
container_title British journal of haematology
container_volume 114
creator Noguchi, Toshio
Ikeda, Kazuma
Yamamoto, Kazuhiko
Yoshida, Isao
Ashiba, Atsuko
Tsuchiyama, Junjiro
Shinagawa, Katsuji
Yoshino, Tadashi
Takata, Minoru
Harada, Mine
description Epstein‐Barr virus (EBV)‐encoded latent membrane protein 1 (LMP‐1) is essential for immortalization of B cells by EBV, protects the infected cells from apoptotic cell death and induces Bcl‐2 expression. Suppression of LMP‐1 expression by antisense oligodeoxynucleotides (AS‐oligo) to LMP‐1 inhibits proliferation, promotes apoptosis and suppresses Bcl‐2 expression in EBV‐transformed B cells. However, the function of LMP‐1 expression in EBV‐positive natural killer (NK) cell lymphoma cells has not been reported previously. We examined the function of LMP‐1 in two EBV‐positive NK cell lymphoma cell lines (NK‐YS and YT) through suppressing LMP‐1 expression by AS‐oligo to LMP‐1. The AS‐oligo to LMP‐1 suppressed LMP‐1 mRNA and protein expression in two EBV‐positive NK cell lymphoma cell lines, as well as in an EBV‐transformed B‐cell line (CMG‐1). Proliferation was inhibited, apoptosis was induced and Bcl‐2 expression was suppressed in CMG‐1 cells, but none of these events were observed in NK‐YS or YT cells. These results suggest that proliferation, inhibition of apoptosis and Bcl‐2 expression in EBV‐positive NK cell lymphoma cells are not directly regulated by LMP‐1 as in EBV‐transformed B‐cell lines, but are probably mediated through other signal transducing systems.
doi_str_mv 10.1046/j.1365-2141.2001.02887.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71037209</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71037209</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3</originalsourceid><addsrcrecordid>eNqNkc9uEzEQxlcIREPhFZAvIJCaYK-d3eyBQ1MFCqrEBXq1bO9s4-BdLx5vm9x4hD5jX4ML3iSiV07-M7_vm9F8WUYYnTEqig-bGePFfJozwWY5pWxG88WinG2fZJN_hafZhFJaTpNgcZK9QNwkkNM5e56dMCbKnItqkv0576JF6BCId_bG1-C3u24wDny0NSCJnjgVoYukhVYH1QHpg49gO8KI7erBALkJ_i6u02tttY3Wd2dE9b6PHi0S1dVkadzD7_uc4ND3ARATkmiy6nE0SqWlCoHc2jAgebdaXr9PXzH1wsaHFpI-vd2u7ddeO4XR25oYcA7PiB4i6Xzcuy2vE9anptHeAulUHIJy5Kd1DsKeJwePVh3UL7NnjXIIr47nafbj0-r7xeX06tvnLxfnV1MjSlFOtdBa5UqbolJ1NeeFaeqiKgUUJmdcC16URcMrBXOgvK4EMG1qoysGhSgbA_w0e3vwTYv7NQBG2VocJ0jL9APKklFe5rRK4OIAmuARAzSyD7ZVYScZlWPwciPHfOWYrxyDl_vg5TZJXx97DDpt7FF4TDoBb46AQqNck7ZrLD5yghZlJXjiPh64O-tg998DyOXXy_HG_wJ0a9Xl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71037209</pqid></control><display><type>article</type><title>Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Noguchi, Toshio ; Ikeda, Kazuma ; Yamamoto, Kazuhiko ; Yoshida, Isao ; Ashiba, Atsuko ; Tsuchiyama, Junjiro ; Shinagawa, Katsuji ; Yoshino, Tadashi ; Takata, Minoru ; Harada, Mine</creator><creatorcontrib>Noguchi, Toshio ; Ikeda, Kazuma ; Yamamoto, Kazuhiko ; Yoshida, Isao ; Ashiba, Atsuko ; Tsuchiyama, Junjiro ; Shinagawa, Katsuji ; Yoshino, Tadashi ; Takata, Minoru ; Harada, Mine</creatorcontrib><description>Epstein‐Barr virus (EBV)‐encoded latent membrane protein 1 (LMP‐1) is essential for immortalization of B cells by EBV, protects the infected cells from apoptotic cell death and induces Bcl‐2 expression. Suppression of LMP‐1 expression by antisense oligodeoxynucleotides (AS‐oligo) to LMP‐1 inhibits proliferation, promotes apoptosis and suppresses Bcl‐2 expression in EBV‐transformed B cells. However, the function of LMP‐1 expression in EBV‐positive natural killer (NK) cell lymphoma cells has not been reported previously. We examined the function of LMP‐1 in two EBV‐positive NK cell lymphoma cell lines (NK‐YS and YT) through suppressing LMP‐1 expression by AS‐oligo to LMP‐1. The AS‐oligo to LMP‐1 suppressed LMP‐1 mRNA and protein expression in two EBV‐positive NK cell lymphoma cell lines, as well as in an EBV‐transformed B‐cell line (CMG‐1). Proliferation was inhibited, apoptosis was induced and Bcl‐2 expression was suppressed in CMG‐1 cells, but none of these events were observed in NK‐YS or YT cells. These results suggest that proliferation, inhibition of apoptosis and Bcl‐2 expression in EBV‐positive NK cell lymphoma cells are not directly regulated by LMP‐1 as in EBV‐transformed B‐cell lines, but are probably mediated through other signal transducing systems.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1046/j.1365-2141.2001.02887.x</identifier><identifier>PMID: 11472349</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adaptor Proteins, Signal Transducing ; antisense oligodeoxynucleotides ; apoptosis ; Apoptosis - drug effects ; Biological and medical sciences ; Blotting, Western ; Carrier Proteins - genetics ; Cell Division - drug effects ; Cell Line, Transformed ; Cytoskeletal Proteins ; EBV‐positive NK‐cell lymphoma ; Gene Deletion ; Gene Expression - drug effects ; Hematologic and hematopoietic diseases ; Herpesvirus 4, Human ; Humans ; Intracellular Signaling Peptides and Proteins ; Killer Cells, Natural - metabolism ; Killer Cells, Natural - virology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; LIM Domain Proteins ; LMP‐1 ; Lymphoma, T-Cell - metabolism ; Lymphoma, T-Cell - virology ; Medical sciences ; Oligonucleotides, Antisense - pharmacology ; proliferation ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Reverse Transcriptase Polymerase Chain Reaction ; Tumor Cells, Cultured</subject><ispartof>British journal of haematology, 2001-07, Vol.114 (1), p.84-92</ispartof><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3</citedby><cites>FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14067943$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11472349$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Noguchi, Toshio</creatorcontrib><creatorcontrib>Ikeda, Kazuma</creatorcontrib><creatorcontrib>Yamamoto, Kazuhiko</creatorcontrib><creatorcontrib>Yoshida, Isao</creatorcontrib><creatorcontrib>Ashiba, Atsuko</creatorcontrib><creatorcontrib>Tsuchiyama, Junjiro</creatorcontrib><creatorcontrib>Shinagawa, Katsuji</creatorcontrib><creatorcontrib>Yoshino, Tadashi</creatorcontrib><creatorcontrib>Takata, Minoru</creatorcontrib><creatorcontrib>Harada, Mine</creatorcontrib><title>Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Epstein‐Barr virus (EBV)‐encoded latent membrane protein 1 (LMP‐1) is essential for immortalization of B cells by EBV, protects the infected cells from apoptotic cell death and induces Bcl‐2 expression. Suppression of LMP‐1 expression by antisense oligodeoxynucleotides (AS‐oligo) to LMP‐1 inhibits proliferation, promotes apoptosis and suppresses Bcl‐2 expression in EBV‐transformed B cells. However, the function of LMP‐1 expression in EBV‐positive natural killer (NK) cell lymphoma cells has not been reported previously. We examined the function of LMP‐1 in two EBV‐positive NK cell lymphoma cell lines (NK‐YS and YT) through suppressing LMP‐1 expression by AS‐oligo to LMP‐1. The AS‐oligo to LMP‐1 suppressed LMP‐1 mRNA and protein expression in two EBV‐positive NK cell lymphoma cell lines, as well as in an EBV‐transformed B‐cell line (CMG‐1). Proliferation was inhibited, apoptosis was induced and Bcl‐2 expression was suppressed in CMG‐1 cells, but none of these events were observed in NK‐YS or YT cells. These results suggest that proliferation, inhibition of apoptosis and Bcl‐2 expression in EBV‐positive NK cell lymphoma cells are not directly regulated by LMP‐1 as in EBV‐transformed B‐cell lines, but are probably mediated through other signal transducing systems.</description><subject>Adaptor Proteins, Signal Transducing</subject><subject>antisense oligodeoxynucleotides</subject><subject>apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Carrier Proteins - genetics</subject><subject>Cell Division - drug effects</subject><subject>Cell Line, Transformed</subject><subject>Cytoskeletal Proteins</subject><subject>EBV‐positive NK‐cell lymphoma</subject><subject>Gene Deletion</subject><subject>Gene Expression - drug effects</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Herpesvirus 4, Human</subject><subject>Humans</subject><subject>Intracellular Signaling Peptides and Proteins</subject><subject>Killer Cells, Natural - metabolism</subject><subject>Killer Cells, Natural - virology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>LIM Domain Proteins</subject><subject>LMP‐1</subject><subject>Lymphoma, T-Cell - metabolism</subject><subject>Lymphoma, T-Cell - virology</subject><subject>Medical sciences</subject><subject>Oligonucleotides, Antisense - pharmacology</subject><subject>proliferation</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Tumor Cells, Cultured</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqNkc9uEzEQxlcIREPhFZAvIJCaYK-d3eyBQ1MFCqrEBXq1bO9s4-BdLx5vm9x4hD5jX4ML3iSiV07-M7_vm9F8WUYYnTEqig-bGePFfJozwWY5pWxG88WinG2fZJN_hafZhFJaTpNgcZK9QNwkkNM5e56dMCbKnItqkv0576JF6BCId_bG1-C3u24wDny0NSCJnjgVoYukhVYH1QHpg49gO8KI7erBALkJ_i6u02tttY3Wd2dE9b6PHi0S1dVkadzD7_uc4ND3ARATkmiy6nE0SqWlCoHc2jAgebdaXr9PXzH1wsaHFpI-vd2u7ddeO4XR25oYcA7PiB4i6Xzcuy2vE9anptHeAulUHIJy5Kd1DsKeJwePVh3UL7NnjXIIr47nafbj0-r7xeX06tvnLxfnV1MjSlFOtdBa5UqbolJ1NeeFaeqiKgUUJmdcC16URcMrBXOgvK4EMG1qoysGhSgbA_w0e3vwTYv7NQBG2VocJ0jL9APKklFe5rRK4OIAmuARAzSyD7ZVYScZlWPwciPHfOWYrxyDl_vg5TZJXx97DDpt7FF4TDoBb46AQqNck7ZrLD5yghZlJXjiPh64O-tg998DyOXXy_HG_wJ0a9Xl</recordid><startdate>200107</startdate><enddate>200107</enddate><creator>Noguchi, Toshio</creator><creator>Ikeda, Kazuma</creator><creator>Yamamoto, Kazuhiko</creator><creator>Yoshida, Isao</creator><creator>Ashiba, Atsuko</creator><creator>Tsuchiyama, Junjiro</creator><creator>Shinagawa, Katsuji</creator><creator>Yoshino, Tadashi</creator><creator>Takata, Minoru</creator><creator>Harada, Mine</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200107</creationdate><title>Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells</title><author>Noguchi, Toshio ; Ikeda, Kazuma ; Yamamoto, Kazuhiko ; Yoshida, Isao ; Ashiba, Atsuko ; Tsuchiyama, Junjiro ; Shinagawa, Katsuji ; Yoshino, Tadashi ; Takata, Minoru ; Harada, Mine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adaptor Proteins, Signal Transducing</topic><topic>antisense oligodeoxynucleotides</topic><topic>apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Carrier Proteins - genetics</topic><topic>Cell Division - drug effects</topic><topic>Cell Line, Transformed</topic><topic>Cytoskeletal Proteins</topic><topic>EBV‐positive NK‐cell lymphoma</topic><topic>Gene Deletion</topic><topic>Gene Expression - drug effects</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Herpesvirus 4, Human</topic><topic>Humans</topic><topic>Intracellular Signaling Peptides and Proteins</topic><topic>Killer Cells, Natural - metabolism</topic><topic>Killer Cells, Natural - virology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>LIM Domain Proteins</topic><topic>LMP‐1</topic><topic>Lymphoma, T-Cell - metabolism</topic><topic>Lymphoma, T-Cell - virology</topic><topic>Medical sciences</topic><topic>Oligonucleotides, Antisense - pharmacology</topic><topic>proliferation</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Noguchi, Toshio</creatorcontrib><creatorcontrib>Ikeda, Kazuma</creatorcontrib><creatorcontrib>Yamamoto, Kazuhiko</creatorcontrib><creatorcontrib>Yoshida, Isao</creatorcontrib><creatorcontrib>Ashiba, Atsuko</creatorcontrib><creatorcontrib>Tsuchiyama, Junjiro</creatorcontrib><creatorcontrib>Shinagawa, Katsuji</creatorcontrib><creatorcontrib>Yoshino, Tadashi</creatorcontrib><creatorcontrib>Takata, Minoru</creatorcontrib><creatorcontrib>Harada, Mine</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Noguchi, Toshio</au><au>Ikeda, Kazuma</au><au>Yamamoto, Kazuhiko</au><au>Yoshida, Isao</au><au>Ashiba, Atsuko</au><au>Tsuchiyama, Junjiro</au><au>Shinagawa, Katsuji</au><au>Yoshino, Tadashi</au><au>Takata, Minoru</au><au>Harada, Mine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2001-07</date><risdate>2001</risdate><volume>114</volume><issue>1</issue><spage>84</spage><epage>92</epage><pages>84-92</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>Epstein‐Barr virus (EBV)‐encoded latent membrane protein 1 (LMP‐1) is essential for immortalization of B cells by EBV, protects the infected cells from apoptotic cell death and induces Bcl‐2 expression. Suppression of LMP‐1 expression by antisense oligodeoxynucleotides (AS‐oligo) to LMP‐1 inhibits proliferation, promotes apoptosis and suppresses Bcl‐2 expression in EBV‐transformed B cells. However, the function of LMP‐1 expression in EBV‐positive natural killer (NK) cell lymphoma cells has not been reported previously. We examined the function of LMP‐1 in two EBV‐positive NK cell lymphoma cell lines (NK‐YS and YT) through suppressing LMP‐1 expression by AS‐oligo to LMP‐1. The AS‐oligo to LMP‐1 suppressed LMP‐1 mRNA and protein expression in two EBV‐positive NK cell lymphoma cell lines, as well as in an EBV‐transformed B‐cell line (CMG‐1). Proliferation was inhibited, apoptosis was induced and Bcl‐2 expression was suppressed in CMG‐1 cells, but none of these events were observed in NK‐YS or YT cells. These results suggest that proliferation, inhibition of apoptosis and Bcl‐2 expression in EBV‐positive NK cell lymphoma cells are not directly regulated by LMP‐1 as in EBV‐transformed B‐cell lines, but are probably mediated through other signal transducing systems.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>11472349</pmid><doi>10.1046/j.1365-2141.2001.02887.x</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2001-07, Vol.114 (1), p.84-92
issn 0007-1048
1365-2141
language eng
recordid cdi_proquest_miscellaneous_71037209
source Wiley-Blackwell Read & Publish Collection
subjects Adaptor Proteins, Signal Transducing
antisense oligodeoxynucleotides
apoptosis
Apoptosis - drug effects
Biological and medical sciences
Blotting, Western
Carrier Proteins - genetics
Cell Division - drug effects
Cell Line, Transformed
Cytoskeletal Proteins
EBV‐positive NK‐cell lymphoma
Gene Deletion
Gene Expression - drug effects
Hematologic and hematopoietic diseases
Herpesvirus 4, Human
Humans
Intracellular Signaling Peptides and Proteins
Killer Cells, Natural - metabolism
Killer Cells, Natural - virology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
LIM Domain Proteins
LMP‐1
Lymphoma, T-Cell - metabolism
Lymphoma, T-Cell - virology
Medical sciences
Oligonucleotides, Antisense - pharmacology
proliferation
Proto-Oncogene Proteins c-bcl-2 - genetics
Reverse Transcriptase Polymerase Chain Reaction
Tumor Cells, Cultured
title Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl‐2 suppression in Epstein‐Barr virus (EBV)‐transformed B‐lymphoblastoid cells, but not in EBV‐positive natural killer cell lymphoma cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A01%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antisense%20oligodeoxynucleotides%20to%20latent%20membrane%20protein%201%20induce%20growth%20inhibition,%20apoptosis%20and%20Bcl%E2%80%902%20suppression%20in%20Epstein%E2%80%90Barr%20virus%20(EBV)%E2%80%90transformed%20B%E2%80%90lymphoblastoid%20cells,%20but%20not%20in%20EBV%E2%80%90positive%20natural%20killer%20cell%20lymphoma%20cells&rft.jtitle=British%20journal%20of%20haematology&rft.au=Noguchi,%20Toshio&rft.date=2001-07&rft.volume=114&rft.issue=1&rft.spage=84&rft.epage=92&rft.pages=84-92&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1046/j.1365-2141.2001.02887.x&rft_dat=%3Cproquest_cross%3E71037209%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4747-b4bba2abc69ad9536cfd6974e6c213b43676f39ae5e03d94e1bcdcb91e647fce3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71037209&rft_id=info:pmid/11472349&rfr_iscdi=true